BRPI0909164A2 - método e composições para o tratamento de câncer - Google Patents

método e composições para o tratamento de câncer

Info

Publication number
BRPI0909164A2
BRPI0909164A2 BRPI0909164A BRPI0909164A BRPI0909164A2 BR PI0909164 A2 BRPI0909164 A2 BR PI0909164A2 BR PI0909164 A BRPI0909164 A BR PI0909164A BR PI0909164 A BRPI0909164 A BR PI0909164A BR PI0909164 A2 BRPI0909164 A2 BR PI0909164A2
Authority
BR
Brazil
Prior art keywords
compositions
cancer treatment
cancer
treatment
Prior art date
Application number
BRPI0909164A
Other languages
English (en)
Portuguese (pt)
Inventor
Angelika Burger
Bernardus Rademaker
Hans Hendriks
Original Assignee
Komipharm Int Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Komipharm Int Co Ltd filed Critical Komipharm Int Co Ltd
Publication of BRPI0909164A2 publication Critical patent/BRPI0909164A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0909164A 2008-03-27 2009-03-24 método e composições para o tratamento de câncer BRPI0909164A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3998708P 2008-03-27 2008-03-27
US12/408,864 US20090246291A1 (en) 2008-03-27 2009-03-23 Method and compositions for treatment of cancer
PCT/US2009/038104 WO2009120697A2 (en) 2008-03-27 2009-03-24 Method and compositions for treatment of cancer

Publications (1)

Publication Number Publication Date
BRPI0909164A2 true BRPI0909164A2 (pt) 2016-06-21

Family

ID=41114644

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909164A BRPI0909164A2 (pt) 2008-03-27 2009-03-24 método e composições para o tratamento de câncer

Country Status (20)

Country Link
US (2) US20090246291A1 (enExample)
EP (1) EP2268292B1 (enExample)
JP (2) JP5543956B2 (enExample)
KR (1) KR101634138B1 (enExample)
CN (2) CN102046187A (enExample)
AU (1) AU2009228378B2 (enExample)
BR (1) BRPI0909164A2 (enExample)
CA (1) CA2719766C (enExample)
CY (1) CY1120536T1 (enExample)
DK (1) DK2268292T3 (enExample)
ES (1) ES2656762T3 (enExample)
HU (1) HUE036609T2 (enExample)
LT (1) LT2268292T (enExample)
MX (1) MX2010010621A (enExample)
PL (1) PL2268292T3 (enExample)
PT (1) PT2268292T (enExample)
RU (1) RU2508116C2 (enExample)
SI (1) SI2268292T1 (enExample)
WO (1) WO2009120697A2 (enExample)
ZA (1) ZA201006988B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
PT2475362T (pt) * 2009-09-10 2019-05-27 Kominox Inc Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos
US8795738B2 (en) * 2009-11-12 2014-08-05 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US11084811B2 (en) 2010-03-01 2021-08-10 Oncternal Therapeutics, Inc. Compounds for treatment of cancer
EP2593101A4 (en) * 2010-07-18 2014-01-01 Niiki Pharma Inc POLYTHERAPY USING RUTHENIUM COMPLEX
WO2012027481A1 (en) * 2010-08-24 2012-03-01 Gtx, Inc. Compounds for treatment of cancer
US20120251628A1 (en) * 2011-03-30 2012-10-04 Young Joo Min Compositions and methods for treatment of cancer
JP2014513698A (ja) * 2011-05-12 2014-06-05 ボード・オヴ・リージェンツ，ユニヴァーシティ・オヴ・テキサス・システム がん治療保護のためのヒ素の使用
US8834938B2 (en) 2011-05-18 2014-09-16 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US20160184356A1 (en) * 2013-03-15 2016-06-30 Ke Jian Jim Liu Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko) 2013-03-15 2013-09-23 박상채 항암 활성 증진용 한약재 및 이의 제조방법
JP6851826B2 (ja) * 2013-07-19 2021-03-31 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． がんの治療のためのｐｉｍキナーゼ阻害剤と組み合わせたペプチドエポキシケトンプロテアソーム阻害剤
PL3548044T3 (pl) 2016-12-01 2024-03-04 Eupharma Pty Ltd Kompozycje arsenu
MA52088A (fr) * 2018-03-22 2021-01-27 Komipharm Int Australia Pty Ltd Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication
CN116236505A (zh) * 2023-03-15 2023-06-09 上海市第四人民医院 三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840057D1 (de) * 1997-10-15 2008-11-06 Polarx Biopharmaceuticals Inc Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von Krebs des zentralen Nervensystems
EP1964557B1 (en) * 1997-11-10 2013-01-02 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
EP2042182B1 (en) * 2002-04-10 2013-05-22 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenite for the treatment of malignancy
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) * 2005-08-23 2012-01-17 Stc.Unm Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
US7867492B2 (en) * 2007-10-12 2011-01-11 The John Hopkins University Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

Also Published As

Publication number Publication date
ZA201006988B (en) 2012-05-30
SI2268292T1 (en) 2018-03-30
EP2268292A4 (en) 2011-05-11
CA2719766C (en) 2017-10-31
CA2719766A1 (en) 2009-10-01
WO2009120697A4 (en) 2010-04-15
CY1120536T1 (el) 2019-07-10
US20180055812A1 (en) 2018-03-01
JP2011515481A (ja) 2011-05-19
RU2010143893A (ru) 2012-05-10
WO2009120697A2 (en) 2009-10-01
PL2268292T3 (pl) 2018-06-29
MX2010010621A (es) 2011-04-05
WO2009120697A3 (en) 2010-02-18
DK2268292T3 (en) 2018-03-12
EP2268292B1 (en) 2017-12-27
AU2009228378B2 (en) 2014-07-17
KR101634138B1 (ko) 2016-06-28
US20090246291A1 (en) 2009-10-01
CN104997808A (zh) 2015-10-28
ES2656762T3 (es) 2018-02-28
JP5543956B2 (ja) 2014-07-09
LT2268292T (lt) 2018-03-26
HUE036609T2 (hu) 2018-07-30
JP2014101387A (ja) 2014-06-05
PT2268292T (pt) 2018-02-19
AU2009228378A1 (en) 2009-10-01
KR20110009664A (ko) 2011-01-28
EP2268292A2 (en) 2011-01-05
CN102046187A (zh) 2011-05-04
RU2508116C2 (ru) 2014-02-27

Similar Documents

Publication Publication Date Title
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
BRPI0811589A2 (pt) Composição farmacêutica e método para tratar câncer
BRPI0908854A2 (pt) composições e métodos para o tratamento de tumor de origem hematopoética
BRPI1008566A2 (pt) métodos e composições para o diagnóstico e tratamento de câncer
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0810206A2 (pt) Método de tratar câncer
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BRPI1008564A2 (pt) métodos e composições para o dignóstico e tratamento de câncer
BRPI1011325A2 (pt) composições e métodos para o tratamento de inflamação
PT2434891T (pt) Métodos para tratamento de cancro e afeções não neoplásicas
BRPI0807918A2 (pt) composições e método para preservação de tecido
BRPI1010874A8 (pt) composição para o tratamento de câncer de próstata
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI1007600A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BRPI0908635A2 (pt) composto, composição farmacêutica e método de tratamento de câncer
BRPI0911112A2 (pt) composições e métodos para o tratamento do câncer de mama
PT2632452T (pt) Compostos e composições para o tratamento do cancro
BRPI0908715A2 (pt) métodos para tratamento da psoríase
BRPI0922884A2 (pt) compostos para tratamento de câncer
BRPI0909016A2 (pt) anticorpos úteis para o tratamento do câncer

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: KOMIPHARM INTERNATIONAL CO., LTD. (KR)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: KOMIPHARM INTERNATIONAL CO., LTD. (KR)

B25A Requested transfer of rights approved

Owner name: KOMINOX, INC (KY)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]